Tiny talk tweaks could transform diabetes care

NCT ID NCT07129915

First seen Nov 21, 2025

Summary

This study tests whether training doctors in 'linguistic nudging'—a gentle way to guide conversations—helps people with type 2 diabetes make better treatment decisions and stick to their care plans. 250 adults from one hospital in China will be randomly assigned to either receive this enhanced communication plus a medication-tracking app, or standard care. The goal is to see if this approach improves blood sugar control, self-management, and satisfaction with care over six months.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Xiang'an Hospital Affiliated to Xiamen University

    RECRUITING

    Xiamen, Fujian, 0592361101, China

    Contact Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

linguistic nudging training and medication preference app

What this could lead to

If it works, this could point toward a simple, low-cost way to improve diabetes self-management and doctor-patient communication.

What could go wrong

This is a small, early-stage trial testing a behavioral intervention, not a drug. Results may not apply to other settings, and the effect on blood sugar control may be modest.

Conditions

The condition(s) this trial relates to.

type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.